[go: up one dir, main page]

MX2018003549A - Composicion limpiadora auto-espumante que contiene propionato de clobetasol y su uso en el tratamiento de la psoriaris. - Google Patents

Composicion limpiadora auto-espumante que contiene propionato de clobetasol y su uso en el tratamiento de la psoriaris.

Info

Publication number
MX2018003549A
MX2018003549A MX2018003549A MX2018003549A MX2018003549A MX 2018003549 A MX2018003549 A MX 2018003549A MX 2018003549 A MX2018003549 A MX 2018003549A MX 2018003549 A MX2018003549 A MX 2018003549A MX 2018003549 A MX2018003549 A MX 2018003549A
Authority
MX
Mexico
Prior art keywords
composition
clobetasol propionate
self
psoriaris
treatment
Prior art date
Application number
MX2018003549A
Other languages
English (en)
Other versions
MX375026B (es
Inventor
Christophe BUGE Jean-
NADAUFOURCADE Karine
Original Assignee
Galderma Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Res & Dev filed Critical Galderma Res & Dev
Publication of MX2018003549A publication Critical patent/MX2018003549A/es
Publication of MX375026B publication Critical patent/MX375026B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/046—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/24—Phosphorous; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/22—Gas releasing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/88—Two- or multipart kits

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Detergent Compositions (AREA)

Abstract

La presente invención se refiere a una composición autoespumante destinada a una aplicación tópica, que comprende un medio cosmética o farmacéuticamente compatible con aplicación tópica y propionato de clobetasol. Esta composición puede comprender una pequeña cantidad de tensioactivos espumantes. Esta composición comprende: - al menos una composición intermediaria B que comprende un agente generador de gas, - al menos una composición intermediaria A que comprende un agente activador para el agente generador de gas, y - propionato de clobetasol contenido en al menos una de las composiciones intermediarias A y B. La presente invención también se refiere a un kit o recipiente único con varios compartimientos que contiene tal composición.
MX2018003549A 2015-09-29 2016-09-27 Composición limpiadora auto-espumante que contiene propionato de clobetasol y su uso en el tratamiento de la psoriaris. MX375026B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1559207A FR3041539B1 (fr) 2015-09-29 2015-09-29 Composition nettoyante auto-moussante contenant du propionate de clobetasol, et son utilisation dans le traitement du psoriasis.
PCT/EP2016/073011 WO2017055294A1 (fr) 2015-09-29 2016-09-27 Composition nettoyante auto-moussante contenant du propionate de clobétasol, et son utilisation dans le traitement du psoriasis

Publications (2)

Publication Number Publication Date
MX2018003549A true MX2018003549A (es) 2018-06-18
MX375026B MX375026B (es) 2025-03-06

Family

ID=54848735

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018003549A MX375026B (es) 2015-09-29 2016-09-27 Composición limpiadora auto-espumante que contiene propionato de clobetasol y su uso en el tratamiento de la psoriaris.

Country Status (9)

Country Link
US (1) US10821076B2 (es)
EP (1) EP3355866B1 (es)
JP (1) JP2018529772A (es)
KR (1) KR20180052131A (es)
CN (1) CN108289854A (es)
AU (1) AU2016330328B2 (es)
FR (1) FR3041539B1 (es)
MX (1) MX375026B (es)
WO (1) WO2017055294A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11364190B2 (en) * 2019-07-30 2022-06-21 L'oreal Acid perfluoro-free self-foaming facial cleanser composition
US11253111B2 (en) 2019-08-22 2022-02-22 Gpcp Ip Holdings Llc Skin care product dispensers and associated self-foaming compositions

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6649186B1 (en) 1996-09-20 2003-11-18 Ethypharm Effervescent granules and methods for their preparation
JP4659980B2 (ja) 1997-11-07 2011-03-30 株式会社メディオン・リサーチ・ラボラトリーズ 二酸化炭素含有粘性組成物
FR2761600B1 (fr) * 1998-06-19 2000-03-31 Oreal Composition moussante pour le lavage et le traitement des cheveux et/ou du cuir chevelu a base d'un principe actif, d'un tensioactif anionique, d'un tensioactif amphotere et d'un agent propenetrant
AUPP583198A0 (en) * 1998-09-11 1998-10-01 Soltec Research Pty Ltd Mousse composition
US5952372A (en) 1998-09-17 1999-09-14 Mcdaniel; William Robert Method for treating rosacea using oral or topical ivermectin
US6177092B1 (en) 1998-11-10 2001-01-23 Color Access, Inc. Self-foaming cleansing systems
US6133310A (en) 1999-08-26 2000-10-17 Parks; L. Dean Method of treatment of rosacea
US6399652B1 (en) 2000-06-29 2002-06-04 L. Dean Parks Method of treating acne vulgaris using avermectin compound
FR2830415B1 (fr) 2001-10-09 2004-07-09 Rhodia Chimie Sa Utilisation d'une composition a base de gomme xanthane en tant que stabilisant de mousses molles, et les mousses a base de cette composition
EP1556009B2 (en) 2002-10-25 2021-07-21 Foamix Pharmaceuticals Ltd. Cosmetic and pharmaceutical foam
FR2854074B1 (fr) 2003-04-24 2007-11-23 Galderma Res & Dev Utilisation de l'ivermectine pour le traitement de desordres dermatologiques
US20050123487A1 (en) 2003-12-08 2005-06-09 Spadini Alessandro L. Stable nonaqueous liquid reactive skin care and cleansing packaged product
US20060057075A1 (en) * 2004-08-02 2006-03-16 Moshe Arkin Pharmaceutical and cosmeceutical wash-off mousse shampoo compositions, processes for preparing the same and uses thereof
CA2548532C (en) 2004-09-27 2014-12-02 Jan De Rijk Methods and compositions for treatment of water
BRPI0709674A2 (pt) 2006-03-31 2011-12-06 Stiefel Res Australia Pty Ltd gel de suspensão espumante
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
FR2924944A1 (fr) 2007-12-18 2009-06-19 Galderma Sa Composition a base d'une avermectine et du soufre ou d'un derive du soufre, notamment pour le traitement de la rosacee
US10589134B2 (en) 2008-01-30 2020-03-17 Kimberly-Clark Worldwide, Inc. Hand health and hygiene system for hand health and infection control
DE102008029357A1 (de) 2008-06-20 2009-12-24 Schwan-Stabilo Cosmetics Gmbh & Co. Kg Schäumende kosmetische Zubereitung
JP2012516320A (ja) 2009-01-30 2012-07-19 イッスム リサーチ デベロプメント カンパニー オブ ザ ヘブライ ユニバーシティ オブ エルサレム リミテッド 爪および皮膚を処置するための組成物
FR2943914A1 (fr) 2009-04-06 2010-10-08 Fabre Pierre Dermo Cosmetique Flacon mousseur comprenant une composition pharmaceutique
US20100291160A1 (en) * 2009-05-13 2010-11-18 Carver David R Pharmaceutical system for trans-membrane delivery
US20110236503A1 (en) 2010-03-23 2011-09-29 Cosmalabs International, Llc Topical Skincare Composition
WO2012001065A2 (en) 2010-06-30 2012-01-05 Galderma Research & Development Method for preventing or treating skin tumor
EP2620138B1 (en) * 2010-09-24 2016-12-07 Daido Chemical Corporation Foam-type external skin preparation
FR2969492B1 (fr) 2010-12-23 2013-07-05 Galderma Res & Dev Mousses dermatologiques obtenues a partir d'un gel ou d'une suspension contenant de l'adapalene
FR2969491B1 (fr) 2010-12-23 2013-07-12 Galderma Res & Dev Mousses dermatologiques obtenues a partir d'un gel ou d'une suspension contenant une combinaison d'adapalene et de bpo
FR2969493B1 (fr) 2010-12-23 2013-07-05 Galderma Res & Dev Mousses dermatologiques obtenues a partir d'un gel ou d'une suspension contenant du bpo
US9301935B2 (en) 2013-06-10 2016-04-05 Naeem Uddin Broad spectrum pharmacological composition for treatment of various infections and diseases and methods of use
EP3010487A4 (en) * 2013-06-17 2016-12-07 Contract Pharmaceuticals Ltd NON-AEROSOL FOAM FOR TOPICAL ADMINISTRATION
CN113559083A (zh) 2013-12-04 2021-10-29 盖尔德马研究及发展公司 包含类维生素a的脂质微胶囊
KR102363217B1 (ko) 2014-03-28 2022-02-14 갈데르마 리써어치 앤드 디벨로프먼트 벤조일 퍼옥시드를 함유하는 린스-오프 화학적 무스
RU2016141961A (ru) 2014-03-28 2018-04-28 Галдерма Ресерч Энд Девелопмент Несмываемая химическая пена, содержащая пероксид бензоила
CN104382863B (zh) 2014-11-29 2017-07-07 河南后羿实业集团有限公司 一种禽用伊维菌素泡腾颗粒

Also Published As

Publication number Publication date
CN108289854A (zh) 2018-07-17
FR3041539B1 (fr) 2018-10-26
AU2016330328A1 (en) 2018-05-17
KR20180052131A (ko) 2018-05-17
US10821076B2 (en) 2020-11-03
EP3355866B1 (fr) 2020-03-18
EP3355866A1 (fr) 2018-08-08
US20180280299A1 (en) 2018-10-04
WO2017055294A1 (fr) 2017-04-06
FR3041539A1 (fr) 2017-03-31
JP2018529772A (ja) 2018-10-11
MX375026B (es) 2025-03-06
AU2016330328B2 (en) 2022-04-07

Similar Documents

Publication Publication Date Title
MX378653B (es) Composicion limpiadora auto-espumante para enjuagar que contiene ivermectina.
BR112016022293A2 (pt) Composição que contém peróxido de benzoíla, uso cosmético de uma composição, medicamento destinado a uma aplicação tópica sobre a pele, kit e processo de preparação de uma composição autoespumante
BR112016022340A2 (pt) Composição, uso cosmético de uma composição, medicamento e kit
MX388493B (es) Champú concentrado que comprende una hidrofluoroolefina o una hidroclorofluoroolefina para suministrar beneficios de propiedades de dosificación en espuma y composicionales.
MX2016016216A (es) Metodo para el tratamiento del cabello con un acondicionador concentrado.
MX371218B (es) Método para tratar el cabello.
SV2017005461A (es) Benzamidas sustituidas con 1,3-tiazol-2-ilo
MX371217B (es) Método para tratar cabello.
MX2017013537A (es) Composiciones concentradas para la limpieza personal y metodos.
CL2015002860A1 (es) Antagonistas de la alfa-v-beta-6 integrina
CL2020000220A1 (es) Composiciones que comprenden aminoácidos para su uso en el tratamiento de enfermedades relacionadas con la disfunción mitocondrial.
MX2015010285A (es) Método para tratar el cabello con espuma.
UY36945A (es) Formulaciones de limpieza con rendimientos mejorados
AR111834A1 (es) Composiciones líquidas estables de inoculantes que comprenden dodecano
CL2011002675A1 (es) Uso de compuestos derivados de nitrato o sulfato de 9-purin-9-il-3,4-dihidroxitetrahidrofuran-2-il-metilo para reducir la presion intraocular ; composicion farmaceutica oftalmica que comprende los compuestos; y formulacion oftalmica de uso topico que los comprende.
MX2018003643A (es) Espuma quimica sin enguaje que contiene trifaroteno y su uso en el tratamiento del acne.
CL2017002214A1 (es) Formulación de combinación de tesofensina y betabloqueante
SV2017005466A (es) Pirazolpiridinaminas como inhibidores de mknk1 y mknk2
AR105350A1 (es) Composición de limpieza con propelente
MX2019006091A (es) Composicion de champu en seco.
MX2018003642A (es) Espuma quimica sin enjuage que contiene propionato de clobetasol y su uso en el tratamiento de la psoriasis.
CL2020000221A1 (es) Composiciones que comprenden aminoácidos para su uso en el tratamiento de enfermedades relacionadas con la disfunción mitocondrial.
CL2015002688A1 (es) Composiciones de agente activo retinoide particulado fino en seco, formulaciones tópicas incluyendo el mismo.
MX2018003640A (es) Espuma quimica sin enguaje que contiene trifaroteno y su uso en el tratamiento de la ictiosis.
MX2018003549A (es) Composicion limpiadora auto-espumante que contiene propionato de clobetasol y su uso en el tratamiento de la psoriaris.

Legal Events

Date Code Title Description
FG Grant or registration